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The ethyl acetate (EA) extract of the stem bark of Cylicodiscus gabunensis (CG) (Mimosaceae) was 
analysed for its anti-diarrhoeal activity. Like loperamide (3 mg/Kg body weight), a single oral dose of C. 
gabunensis ethyl acetate extract (CG-EA) (375, 750 mg/Kg body weight) produced a significant 
decrease in the severity of diarrhoea. To understand the mechanism of its anti-diarrhoeal activity, its 
effect was further evaluated on intestinal transit, castor oil induced intestinal fluid accumulation 
(enteropooling) and electrolyte concentration in the small intestinal fluid. CG-EA produced a decrease 
in intestinal transit (10.26-30.75%), and unlike atropine, it significantly inhibited castor oil induced 
enteropooling. However, it did not alter the electrolyte concentration in intestinal fluid as compared to 
castor oil-treated rats. 
        





In developing countries, a majority of people living in rural 
areas almost exclusively use traditional medicine in 
treating all sorts of diseases including diarrhoea. 
Diarrhoea is a major health problem especially for 
children under the age of 5 and up to 17% of children 
admitted in the paediatrics ward die of diarrhoea. 
Worldwide distribution of diarrhoea accounts for more 
than 5-8 million deaths each year in infants and children 
below 5 years old especially in developing countries 
(Fauci et al., 1998). According to W.H.O. estimates for 
1998, about 7.1 million deaths were caused by diarrhoea 
(Park et al., 2000). The incidence of diarrhoeal diseases 
still remains high despite the efforts of many govern-
ments and international organisations to curb it. It is 
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ural drugs as alternatives to currently used anti-diarrhoeal 
drugs, which are not always free from adverse effects 
(Harman et al., 1992). A range of medicinal plants with 
anti-diarrhoeal properties is widely used by traditional 
healers. However, the effectiveness of many of these 
anti-diarrhoeal traditional medicines has not been 
scientifically evaluated. 
Cylicodiscus gabunensis (Mimosaceae) commonly 
called denya (Ghana), edum (Gabon), adoum, Bokoka 
(Cameroon), bouemon (Ivory Coast) (Chudnoff et al., 
1984) is a large tree with a cylindrical trunk. The stem is 
more or less pyramidal in shape. The bark has a strong 
odour with widespread branches.  The leaves are 
imparipinnate sub sessile, alternate and are slightly 
asymmetrical. The inflorescence is on the branches. The 
flowers are small, 2 - 5 mm long and 2 - 3 mm wide. The 
pods are long, hanging up to 1 m long and 4 cm broad, 
acute at the base and acuminate at the apex 
(Adjanohoun et al., 1996). C. gabunensis (CG) is found in  






Cameroon to Cabinda (Adjanohoun et al., 1996). Four  
saponins were isolated from the alcoholic extract of the 
bark of CG (Tchivounda et al., 1991). Medicinally, the 
barks of the stem are used to prepare remedies for 
gastro-intestinal disorders, headache and rheumatism 
(Adjanohoun et al., 1996).  
The present study investigates the anti-diarrhoeal 
activity of CG against experimentally induced diarrhoea. 
 
 
MATERIALS AND METHODS 
 
Treatment of animals 
 
Wistar albino rats (150-200 g) of both sexes were obtained from the 
animal house of the Centre for Research in Food and Nutrition of 
the Institute of Medical Research and Medicinal Plant Studies 
(IMPM), Yaoundé, Cameroon. The rats were given food and water 
ad libitum. All the animals were kept under laboratory conditions for 
an acclimatization period of 7 days before carrying out the 
experiments. All studies were carried out in groups of 6 rats each.  
Each     rat    was   housed    separately    in    a    metabolic    cage. 
  
 
Collection of plant materials 
 
The barks of the stem of CG were collected in the morning on 
Mount Eloumdem, Yaoundé, Cameroon in January 2004. 
Identification of the plant was confirmed in the National Herbarium 
Yaoundé (reference number of the plant: 21574/SRF/Cam). The 
barks were then air-dried at room temperature. The dry barks were 
ground into a fine powder.  
 
 
Preparation of the plant extract 
 
This was done by soaking the dry plant powder (200 g) in a bottle 
(1.5 l) of ethyl acetate (EA) and kept for 72 h. The plant-ethyl 
acetate mixture was then sieved. The filtrate (extract) was 
concentrated by evaporating the ethyl acetate using a rotary 
evaporator. The C. gabunensis ethyl acetate extract (CG-EA) was 




Drugs and chemicals 
 
Atropine sulphate and loperamide (standard reference anti-
diarrhoeal drugs), castor oil (laxative agent), normal saline solution 
(9% NaCl), charcoal meal (10% activated charcoal in 5% gum 




Castor oil-induced diarrhoea 
 
24 rats were allowed to fast for 18 h and divided into 4 groups of 6 
animals each. All groups received castor oil at a dose of 1 
ml/animal orally (p.o.) (Doherty et al., 1981). 30 min after castor oil 
administration, the first group (control group) received vehicle (0.5% 
Tween 80 in distilled water), the second and third groups CG-EA 
375 mg/kg and 750 mg/kg body weight, respectively. The fourth 
group received the reference drug, loperamide (3 mg/kg orally). 
After this administration, the animals were placed separately in 
metabolic cages with filter paper, which was changed every hour. 
The severity of diarrhoea was assessed each hour for 6 h. The total  
number  of  faeces  and  diarrhoea  faeces excreted  and  the   total 




weight of faeces were recorded within a period of 24 h and 
compared with the control group. The total number of diarrhoea 
faeces of the control group was considered 100%. The results were 




Study of small intestinal transit 
 
This was done according to the method proposed by Mujumdar et 
al. (1998) using charcoal meal as a diet marker. The rats were 
divided into 4 groups of 6 animals each. The first group (the control 
group) was orally administered the vehicle (0.5% Tween 80 in 
distilled water). The second and third groups orally received CG-
AE, 375 mg/kg and 750 mg/kg body weight respectively. The fourth 
group also orally received the standard drug, atropine sulphate (5 
mg/kg body weight). 30 min after administration, each animal was 
given 1 ml of charcoal meal orally (10% activated charcoal in 5% 
gum acacia). Also, 30 min after this administration, each animal 
was sacrificed and the distance covered by the charcoal meal in the 
intestine, from the pylorus to the caecum was measured and 
expressed as a percentage of distance moved. 
 
 
Castor oil-induced enteropooling and electrolyte secretion  
 
Intraluminal fluid accumulation was determined by the method of 
Robert et al. (1976). The rats were divided into 5 groups of 6 
animals each. Group one received 2 ml of normal saline solution 
and group 2 received 2 ml of castor oil. Groups 3, 4 and 5 received 
atropine sulphate (0.1 mg/kg) through the intraperitonial route (i.p.), 
375 mg/kg p.o. CG-EA and 750 mg/kg p.o. CG-EA, respectively, 
one hour before the oral administration of castor oil. Two hours 
later, the rats were anaesthetised with ether and sacrificed. The 
edges of the small intestine were tied with thread and the intestine 
was removed and weighed. The intestinal content was collected by 
squeezing it into a graduated tube and the volume measured. The 
intestine was reweighed and the difference between full and empty 
intestines was calculated. The Na+ and K+ concentrations were 
measured in the supernatant after centrifuging the intraluminal fluid 





The freshly prepared extract was qualitatively tested for the 
presence of chemical constituents such as tannins, alkaloids, 
saponins, flavonoids, sterols and/or triterpenes and reducing 
sugars. They were identified by characteristic colour changes using   





The values were expressed as mean ± standard deviation. The 
statistical analysis of data was by Analysis of Variance (ANOVA) 
using 5% level of significance. The statistical package used was 
SPSS 9.0.  A One-way ANOVA enabled the significant differences 
between the values to be observed. The Duncan test was used to 





Effect of CG-EA and castor oil-induced diarrhoea 
 
In the castor oil-induced diarrhoea experiment, the rats 
that did not receive the plant extract, showed typical 
diarrhoea     signs     such      as     watery   and   frequent  
  




Table 1. Effect of C. gabunensis ethyl acetate extract (CG-EA) on castor oil-induced diarrhoea. 
 
Group  Total number of 
faeces 








Castor oil (1mL) + vehicle 
(0.5% Tween 80) 24.83 ± 4.53
d 20.83 ± 5.115b 0% 7.38 ± 2.20c 0% 
Loperamide (3 mg/kg) + 
castor oil (1 mL) 9.83 ± 0.93
a 6.17 ± 1.60a 70.38% 1.76 ± 0.83a 76.83% 
CG-EA (375 mg/kg) + castor 
oil (1 mL) 21.50 ± 2.43
cd 4.33 ± 2.65a 79.22% 5.04 ± 1.47b 31.69% 
CG-EA (750 mg/kg) + castor 
oil (1 mL) 20.50 ± 4.37
c 7.17 ± 1.32a 65.58% 5.04 ± 0.58b 31.71% 
 
  Values in the same column with different letter superscripts are significantly different (p<0.05). 
 
 
Table 2. Effect of C. gabunensis ethyl acetate extract (CG-EA) on charcoal-induced gut transit changes. 
 
Group Percentage of distance travelled by charcoal meal Percentage of inhibition 
Vehicle (0.5% Tween 80) 74.57 ± 9.90d 0% 
Atropine sulphate (5 mg/kg) 40.32 ± 4.25a 45.93% 
CG-EA (375 mg/kg)  66.93 ± 7.18cd 10.26% 
CG-EA (750 mg/kg)  51.64 ± 4.25b 30.75% 
 




defecation. The EA extract of CG produced a marked 
anti-diarrhoeal effect in the rats. Both doses of CG-EA 
significantly decreased (p<0.05) the total number of wet 
faeces produced by administration of castor oil (4.33 at 
the dose of 375 mg/kg and 7.17 at the dose of 750 
mg/kg) as compared to the castor oil-treated control 
group (20.83). The percentage of inhibition of castor oil 
induced diarrhoea in CG-EA treated rats was 79.22 and 
65.58% respectively at 375 and 750 mg/kg dose. 
The effect of CG-EA was similar to that of the standard 
drug, loperamide (3 mg/kg) which produced an inhibition 
of 70.38% (Table 1). The average weight of faeces in the 
control group was 7.38 g. Treatment with both doses of 
CG-EA significantly reduced (p<0.05) the weight of   
faeces  to  5.04 g  (Table 1). 
 
 
Effect of CG-EA on charcoal-induced gut in transit 
changes 
 
The administration of CG-EA also slowed down the 
propulsion of charcoal meal through the gastro-intestinal 
tract when compared to the castor oil-treated rats. The 
percentage of intestinal length travelled by charcoal meal 
in CG-EA pre-treated (375 and 750 mg/kg) and castor oil-
treated rats was 66.93, 51.64 and 74.58%, respectively. 
Atropine on its part, produced a marked decrease in the 
propulsive movement and the intestinal length travelled 
by charcoal meal was 40.33 (Table 2).  
 
 
Effect of CG-EA on castor oil-induced enteropooling 
and electrolyte secretion 
 
CG-EA was also found to possess an anti-enteropooling 
activity. Oral administration of castor oil produced a 
significant increase (p<0.05) in the intestinal fluid (3.12 
ml) as compared to the normal rats (1.28 ml). CG-EA 
when given orally one hour before castor oil, significantly 
inhibited (p<0.05) the enteropooling; 1.46 ml (375 mg/kg) 
and 1.66 ml (750 mg/kg). The volume of intestinal fluid 
was similar to that obtained in the normal group (1.28 ml) 
(Table 3). The weight of the intestinal content was also 
significantly decreased following treatment with castor oil 
(from 3.54 to 2.02 g in the normal rats).      However, CG-
EA produced a marginal decrease in the weight of the 
intestinal content. The secretions were more viscous. 
Treatment of rats with castor oil significantly increased 
(p<0.05) the Na+ concentration to 11 meq/l as compared 
to the control group (8.75 meq/l).CG-EA  at  both  doses  
as well as atropine sulphate pre-treatment did not alter 
the Na+ concentration  in the intestinal  fluid, similar to the 
castor oil treated group. None of the treatment produced 
a      significant     change    in    the    K+     concentration.  
  




Table 3. Effect of C. gabunensis ethyl acetate extract (CG-EA) on castor oil enteropooling and electrolyte secretion. 
 
Group Volume of intestinal content (ml) 




Concentration of K+ 
(meq/l) 
Castor oil (2 ml) 3.12 ± 0.37d 3.54 ± 0.61c 11.00 ± 1.50a 5.64 ± 1.41a 
Normal saline (2 ml) 1.28 ± 0.24ab 1.02 ± 0.25ab 8.75 ± 1.49ab 6.34 ± 0.98ab 
Atropine sulphate + 
castor oil (2 ml) 1.80 ± 0.31
c 2.46 ± 0.36b 15.83 ± 3.46ab 7.78 ± 0.20ab 
CG-EA (350 mg/kg) + 
castor oil (2 ml) 1.46 ± 0.28
abc 2.44 ± 0.24b 15.68 ± 4.06ab 7.39 ± 2.27ab 
CG-EA (750 mg/kg) + 
castor oil (2 ml) 1.66 ± 0.37
bc 2.40 ± 0.31b 17.67 ± 7.27b 7.79 ± 2.01ab 
 





Castor oil causes diarrhoea due to its active metabolite, 
ricinolic acid (Ammon, 1974; Watson, 1962), which 
stimulates peristaltic activity in the small intestine, leading 
to changes in the electrolyte permeability of the intestinal 
mucosa. Its action also stimulates the release of 
endogenous prostaglandin (Galvez et al., 1993). In this 
study, the ethyl acetate extract of CG exhibited a 
significant anti-diarrhoeal activity. Its effect did not 
depend on the dose. The results were similar to that of 
the standard drug loperamide (3 mg/kg) with regard to 
the severity of diarrhoea. CG-EA significantly reduced 
intestinal transit as observed by the decrease in intestinal 
motility of charcoal meal. The extract also led to a 
marked reduction in the weight and the volume of the 
intestinal contents. 
Phytochemical screening revealed the presence of 
tannins, sterol and/or triterpenes and reducing sugars 
(Mabeku et al., unpublished data). Earlier studies showed 
that anti-dysenteric and anti-diarrhoeal properties of 
medicinal plants were due to tannins, alkaloids, saponins, 
flavonoids, sterol and/or triterpenes and reducing sugars 
(Anonymous, 1962; Galvez et al., 1991, 1993; Longanga 
et al., 2000). Hence, tannins, reducing sugars, sterol 
and/or triterpenes may be responsible for the mechanism 
of action of CG-EA anti-diarrhoeal activity. The anti-
diarrhoeal activity of this extract may also be due to the 
presence of denatured proteins, which form protein 
tannates. Protein tannates make the intestinal mucosa 
more resistant and hence, reduce secretion (Tripathi, 
1994). This can be due to the fact that the extract 
increased the reabsorption of water by decreasing 
intestinal motility as observed in the decrease of intestinal 
transit by charcoal meal.  
Loperamide, apart from regulating the gastrointestinal 
tract, is also reported to slow down transit in the small 
intestine, reduce colon flow rate, and consequently any 
effect on colonic motility (Theoderau et al., 1991). 
Atropine significantly reduced intestinal transit time. This 
is possible due to its anticholinergic effect (Brown and 
Taylor, 1996). However, it did not inhibit castor oil-
induced enteropooling, thereby, suggesting that 
mediators other than acetylcholine are involved in castor 
oil-induced enteropooling. Furthermore, a decrease in 
intestinal transit time with atropine could also be due to 
reduction in gastric emptying (Izzo et al., 1999).  
In conclusion, the results of this investigation revealed 
that CG-EA contains pharmacologically active substan-
ce(s) with anti-diarrhoeal properties. These properties 
confirm the use of CG as an anti-diarrhoeal drug as 
proposed by traditional healers. Further research is to be 
carried out to fractionate and purify the extract, in order to 
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